Follow The Filings

BOLT Bolt Biotherapeutics

Bolt Biotherapeutics earnings company data as of 4:46 AM ET 11/6

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by BOLT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BOLT insider trades
  • $5,594 bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Sarah Nemec Senior VP, Finance and PAO
    Buy
    $1,973 509 shares at $3.88 +36% to stake
    Traded Jun 5 Filed Sep 21
    ↗
  2. William P. Quinn CEO
    Buy
    $2,469 637 shares at $3.88 +28% to stake
    Traded Jun 5 Filed Sep 21
    ↗
  3. William P. Quinn CEO
    Buy
    $576 125 shares at $4.61 +5.7% to stake
    Traded Dec 5, 2025 Filed Feb 4
    ↗
  4. Sarah Nemec Senior VP, Finance and PAO
    Buy
    $687 125 shares at $5.49 +15% to stake
    Traded Jun 6, 2025 Filed Oct 24, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 9 sales to cover taxes and 2 stock grants.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K 1.01,1.02,2.01,3.02,5.02,5.03,7.01,8.01,9.01 Filing Doc
8-K 1.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 10 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf